{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:09:29Z","timestamp":1748664569758,"version":"3.41.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.arteri.2015.08.001","type":"journal-article","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T18:34:09Z","timestamp":1442255649000},"page":"143-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nuevas poblaciones con riesgo cardiovascular aumentado: enfermedad cardiovascular en las enfermedades dermatol\u00f3gicas"],"prefix":"10.1016","volume":"28","author":[{"given":"Elena","family":"Godoy-Gij\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Meseguer-Yebra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Palacio-Aller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Vicente","family":"Godoy-Rocati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Lahoz-Rallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2015.08.001_bib0670","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.arteri.2015.08.001_bib0675","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ad.2012.02.003","article-title":"Cardiovascular risk and psoriasis: The role of biologic therapy","volume":"103","author":"Puig","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.arteri.2015.08.001_bib0680","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaad.2013.11.023","article-title":"Increased risk of diabetes mellitus in relation to the severity of psoriasis, concomitant medication, and comorbidity: A nationwide population-based cohort study","volume":"70","author":"Lee","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0685","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2013.06.053","article-title":"Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors","volume":"69","author":"Miller","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0690","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaad.2010.11.046","article-title":"Psoriasis and cardiovascular risk factors: A case-control study on inpatients comparing psoriasis to dermatitis","volume":"66","author":"Shapiro","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0695","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaad.2013.09.020","article-title":"From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies","volume":"70","author":"Hugh","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0700","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1530\/eje.1.02057","article-title":"Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines","volume":"154","author":"Corbetta","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0705","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arteri.2015.08.001_bib0710","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0715","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3899\/jrheum.130874","article-title":"Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort","volume":"41","author":"Bartels","year":"2014","journal-title":"J Rheumatol"},{"issue":"10 Suppl 1","key":"10.1016\/j.arteri.2015.08.001_bib0720","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.06.010","article-title":"Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus","volume":"121","author":"Salmon","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.arteri.2015.08.001_bib0725","first-page":"1789","article-title":"Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus","volume":"35","author":"Rho","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0730","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.HYP.37.4.1075","article-title":"Vascular stiffness in women with systemic lupus erythematosus","volume":"37","author":"Selzer","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.arteri.2015.08.001_bib0735","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.11418","article-title":"Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus","volume":"50","author":"Selzer","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arteri.2015.08.001_bib0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2015.05.024","article-title":"Cardiovascular disease biomarkers across autoimmune diseases","author":"Ahearn","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0745","article-title":"Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: Association with disease activity, nephritis, smoking, and age","author":"Medeiros","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.arteri.2015.08.001_bib0750","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0961203313502570","article-title":"SLE and metabolic syndrome","volume":"22","author":"Parker","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.arteri.2015.08.001_bib0755","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/0961203308093554","article-title":"Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain","volume":"17","author":"Sabio","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.arteri.2015.08.001_bib0760","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.medcli.2014.09.011","article-title":"Metabolic syndrome in patients with systemic lupus erythematosus: causes and consequences","volume":"144","author":"Erdozain","year":"2015","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.arteri.2015.08.001_bib0765","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1517\/14740338.2015.1073259","article-title":"Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review","volume":"14","author":"Benvenuti","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.arteri.2015.08.001_bib0770","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1191\/0961203306lu2267oa","article-title":"Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: Implications in autoimmune-mediated atherosclerosis","volume":"15","author":"Lopez","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.arteri.2015.08.001_bib0775","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1097\/MD.0000000000001183","article-title":"Cardiovascular events in systemic lupus erythematosus: A nationwide study in Spain from the RELESSER Registry","volume":"94","author":"Fernandez-Nebro","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.arteri.2015.08.001_bib0780","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ijcard.2014.07.079","article-title":"Alopecia and its association with coronary heart disease and cardiovascular risk factors: A meta-analysis","volume":"176","author":"Trieu","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0785","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2133.2010.09816.x","article-title":"Association of androgenetic alopecia with metabolic syndrome in men: A community-based survey","volume":"163","author":"Su","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0790","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jdv.12424","article-title":"Androgenetic alopecia is associated with increased arterial stiffness in asymptomatic young adults","volume":"29","author":"Agac","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0795","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ad.2009.10.002","article-title":"Male androgenetic alopecia and cardiovascular risk factors: A case-control study","volume":"101","author":"Arias-Santiago","year":"2010","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.arteri.2015.08.001_bib0800","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaad.2009.10.018","article-title":"Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study","volume":"63","author":"Arias-Santiago","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0805","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1365-4632.2010.04630.x","article-title":"Lipid levels in women with androgenetic alopecia","volume":"49","author":"Arias-Santiago","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0810","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/0974-7753.136747","article-title":"Association between androgenetic alopecia and coronary artery disease in young male patients","volume":"6","author":"Sharma","year":"2014","journal-title":"Int J Trichology"},{"key":"10.1016\/j.arteri.2015.08.001_bib0815","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4103\/2229-5178.137776","article-title":"Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study","volume":"5","author":"Bakry","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.arteri.2015.08.001_bib0820","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2133.2009.09588.x","article-title":"Hypertension and aldosterone levels in women with early-onset androgenetic alopecia","volume":"162","author":"Arias-Santiago","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0825","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archinte.160.2.165","article-title":"Male pattern baldness and coronary heart disease: The Physicians\u2019 Health Study","volume":"160","author":"Lotufo","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arteri.2015.08.001_bib0830","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2340\/00015555-0926","article-title":"A comparative study of dyslipidaemia in men and woman with androgenic alopecia","volume":"90","author":"Arias-Santiago","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0835","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/174182670100800305","article-title":"Early onset of androgenetic alopecia associated with early severe coronary heart disease: A population-based, case-control study","volume":"8","author":"Matilainen","year":"2001","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.arteri.2015.08.001_bib0840","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1468-3083.2008.02704.x","article-title":"Evaluation of lipid levels in androgenetic alopecia in comparison with control group","volume":"23","author":"Sadighha","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0845","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jamadermatol.2013.130","article-title":"Association of androgenetic alopecia with mortality from diabetes mellitus and heart disease","volume":"149","author":"Su","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0850","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D38525G87B","article-title":"Androgenetic alopecia and coronary artery disease in women","volume":"11","author":"Mansouri","year":"2005","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.arteri.2015.08.001_bib0855","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0022-202X(89)90189-9","article-title":"Subcutaneous blood flow in early male pattern baldness","volume":"92","author":"Klemp","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0860","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1677\/joe.0.1560059","article-title":"Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp","volume":"156","author":"Hibberts","year":"1998","journal-title":"J Endocrinol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0865","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0960-0760(94)90025-6","article-title":"Androgen receptors, 5 alpha-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells","volume":"50","author":"Fujimoto","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0870","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-14-0253","article-title":"The polycystic ovary syndrome: A position statement from the European Society of Endocrinology","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/SO100-720320140005212","article-title":"Primary and secondary prevention of metabolic and cardiovascular comorbidities in women with polycystic ovary syndrome","volume":"37","author":"Spritzer","year":"2015","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.arteri.2015.08.001_bib0885","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/cen.12008","article-title":"Prevalence of metabolic syndrome in women with polycystic ovary syndrome","volume":"78","author":"Panidis","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arteri.2015.08.001_bib0890","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arteri.2015.08.001_bib0895","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejogrb.2006.09.009","article-title":"Nitric oxide and fibrinogen in polycystic ovary syndrome: Associations with insulin resistance and obesity","volume":"133","author":"Nacul","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0900","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.fertnstert.2010.02.015","article-title":"Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes","volume":"94","author":"Wiltgen","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.arteri.2015.08.001_bib0905","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.fertnstert.2012.08.049","article-title":"Cardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter?","volume":"99","author":"Di Domenico","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.arteri.2015.08.001_bib0910","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.arteri.2015.08.001_bib0915","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"Toulis","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.arteri.2015.08.001_bib0920","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: A systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.arteri.2015.08.001_bib0925","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.arteri.2015.08.001_bib0930","doi-asserted-by":"crossref","first-page":"E628","DOI":"10.1210\/jc.2012-3908","article-title":"Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome","volume":"98","author":"Moghetti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arteri.2015.08.001_bib0935","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.arteri.2015.08.001_bib0940","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jcem.87.2.8199","article-title":"Altered vascular function in young women with polycystic ovary syndrome","volume":"87","author":"Kelly","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arteri.2015.08.001_bib0945","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2362.2006.01712.x","article-title":"Inflammatory and endothelial markers in women with polycystic ovary syndrome","volume":"36","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.arteri.2015.08.001_bib0950","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arteri.2015.08.001_bib0955","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"Glucose intolerance in polycystic ovary syndrome \u2014 a position statement of the Androgen Excess Society","volume":"92","author":"Salley","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arteri.2015.08.001_bib0960","first-page":"56","article-title":"Metformin use in women with polycystic ovary syndrome","volume":"2","author":"Johnson","year":"2014","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.arteri.2015.08.001_bib0965","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/EJE-09-0733","article-title":"Metformin: An old medication of new fashion: Evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome","volume":"162","author":"Diamanti-Kandarakis","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0970","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.fertnstert.2009.02.078","article-title":"An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome","volume":"94","author":"Karimzadeh","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.arteri.2015.08.001_bib0975","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/humupd\/dmn043","article-title":"Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: Systematic review and meta-analysis","volume":"15","author":"Nieuwenhuis-Ruifrok","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.arteri.2015.08.001_bib0980","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0985","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","article-title":"Incidence of hidradenitis suppurativa and associated factors: A population-based study of Olmsted County, Minnesota","volume":"133","author":"Vazquez","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib0990","first-page":"173","article-title":"Smoking and the skin","volume":"99","author":"Just-Sarobe","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.arteri.2015.08.001_bib0995","doi-asserted-by":"crossref","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.arteri.2015.08.001_bib1000","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1005","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1010","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","article-title":"Deficiency of IL-22 contributes to a chronic inflammatory disease: Pathogenetic mechanisms in acne inversa","volume":"186","author":"Wolk","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cytogfr.2010.11.001","article-title":"IL-10 family of cytokines","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.arteri.2015.08.001_bib1020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cytogfr.2010.08.001","article-title":"IL-20: biological functions mediated through two types of receptor complexes","volume":"21","author":"Wegenka","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.arteri.2015.08.001_bib1025","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1030","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1600-0625.2009.00967.x","article-title":"Long-term efficacy of etanercept in hidradenitis suppurativa: Results from an open-label phase II prospective trial","volume":"19","author":"Pelekanou","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1035","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2340\/00015555-1229","article-title":"Management of recalcitrant hidradenitis suppurativa with ustekinumab","volume":"92","author":"Sharon","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1040","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1365-4632.2010.04545.x","article-title":"A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa","volume":"49","author":"Amano","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1050","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: Potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1055","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: A little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000371877","article-title":"Decreased number of circulating endothelial progenitor cells in hidradenitis suppurativa patients","volume":"230","author":"Matusiak","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.arteri.2015.08.001_bib1065","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2133.2009.09235.x","article-title":"Lichen planus and dyslipidaemia: A case-control study","volume":"161","author":"Dreiher","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1070","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1468-3083.2011.03983.x","article-title":"Lipid levels in patients with lichen planus: A case-control study","volume":"25","author":"Arias-Santiago","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.amjmed.2010.12.025","article-title":"Cardiovascular risk factors in patients with lichen planus","volume":"124","author":"Arias-Santiago","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.arteri.2015.08.001_bib1080","first-page":"ZC92","article-title":"Lipid profile and metabolic syndrome status in patients with oral lichen planus, oral lichenoid reaction and healthy individuals attending a dental college in northern India \u2014 a descriptive study","volume":"8","author":"Krishnamoorthy","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.arteri.2015.08.001_bib1085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/11633600-000000000-00000","article-title":"Alterations in serum lipid profile patterns in oral lichen planus: A cross-sectional study","volume":"13","author":"Lopez-Jornet","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1090","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/jdv.12329","article-title":"Homocysteine and other cardiovascular risk factors in patients with lichen planus","volume":"28","author":"Saleh","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2133.1976.tb15530.x","article-title":"Carbohydrate metabolism in lichen planus","volume":"95","author":"Lowe","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1100","first-page":"121","article-title":"Prevalence of diabetes mellitus amongst oral lichen planus patients. Clinical and pathological characteristics","volume":"7","author":"Romero","year":"2002","journal-title":"Med Oral"},{"key":"10.1016\/j.arteri.2015.08.001_bib1105","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.clindermatol.2013.11.007","article-title":"Atopic dermatitis as a systemic disease","volume":"32","author":"Darlenski","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1115","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ng2020","article-title":"Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema","volume":"39","author":"Sandilands","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.arteri.2015.08.001_bib1120","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.0022-202X.2004.23462.x","article-title":"An association between ulcerative colitis and atopic dermatitis, diseases of impaired superficial barriers","volume":"123","author":"Niwa","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3748\/wjg.v16.i3.299","article-title":"Pulmonary involvement and allergic disorders in inflammatory bowel disease","volume":"16","author":"Tzanakis","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1130","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/jdv.12281","article-title":"Atopy as a risk factor for thyroid autoimmunity in children affected with atopic dermatitis","volume":"28","author":"Pedulla","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1651-2227.2007.00154.x","article-title":"Atopy in childhood idiopathic nephrotic syndrome","volume":"96","author":"Salsano","year":"2007","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.arteri.2015.08.001_bib1140","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jpeds.2010.10.009","article-title":"Total and low-density lipoprotein cholesterol levels are associated with atopy in schoolchildren","volume":"158","author":"Kusunoki","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.arteri.2015.08.001_bib1145","doi-asserted-by":"crossref","first-page":"607192","DOI":"10.1155\/2014\/607192","article-title":"Body mass index and comorbidities in adult severe asthmatics","volume":"2014","author":"Bruno","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.arteri.2015.08.001_bib1150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/000331970305400109","article-title":"Increased immunoglobulin E response in acute coronary syndromes","volume":"54","author":"Erdogan","year":"2003","journal-title":"Angiology"},{"key":"10.1016\/j.arteri.2015.08.001_bib1155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.20452\/pamw.1036","article-title":"Increase in plasma sCD23 levels precedes immunoglobulin E elevation after coronary artery bypass graft surgery","volume":"121","author":"Marciniak-Sroka","year":"2011","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.arteri.2015.08.001_bib1160","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1536\/jhj.44.593","article-title":"C-reactive protein and immunoglobulin-E response to coronary artery stenting in patients with stable angina","volume":"44","author":"Erdogan","year":"2003","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.arteri.2015.08.001_bib1165","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/cea.12408","article-title":"Atopy and cause-specific mortality","volume":"44","author":"Skaaby","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.arteri.2015.08.001_bib1170","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijcard.2013.11.029","article-title":"Links between allergy and cardiovascular or hemostatic system","volume":"170","author":"Potaczek","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1175","doi-asserted-by":"crossref","first-page":"e000062","DOI":"10.1136\/bmjopen-2011-000062","article-title":"A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: A cross-sectional study","volume":"1","author":"Thyssen","year":"2011","journal-title":"BMJ Open"},{"key":"10.1016\/j.arteri.2015.08.001_bib1180","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.2337\/db09-0081","article-title":"Linkage disequilibrium mapping of the replicated type 2 diabetes linkage signal on chromosome 1q","volume":"58","author":"Prokopenko","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.arteri.2015.08.001_bib1185","series-title":"Filaggrin","first-page":"311","article-title":"Filaggrin, the skin barrier and diabetes","author":"Godoy-Gij\u00f3n","year":"2014"},{"key":"10.1016\/j.arteri.2015.08.001_bib1190","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2340\/00015555-1443","article-title":"Co-existence of chronic urticaria and metabolic syndrome: Clinical implications","volume":"93","author":"Ye","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1195","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5114\/pdia.2014.43191","article-title":"Cardiovascular safety of antihistamines","volume":"31","author":"Olasinska-Wisniewska","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2005.08.007","article-title":"Kounis syndrome (allergic angina and allergic myocardial infarction): A natural paradigm?","volume":"110","author":"Kounis","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1205","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arteri.2015.08.001_bib1210","doi-asserted-by":"crossref","first-page":"e4928","DOI":"10.1136\/bmj.e4928","article-title":"Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: Cohort study","volume":"345","author":"Fardet","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.arteri.2015.08.001_bib1215","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/archinternmed.2009.297","article-title":"Glucocorticoid use and risk of atrial fibrillation or flutter: A population-based, case-control study","volume":"169","author":"Christiansen","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arteri.2015.08.001_bib1220","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0889-8529(05)70271-1","article-title":"Diabetes management in special situations","volume":"26","author":"Hirsch","year":"1997","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.arteri.2015.08.001_bib1225","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/bjd.13027","article-title":"Hypertriglyceridaemia with acitretin use: A proposal for its management in the context of overall cardiovascular risk","volume":"171","author":"Chan","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000330326","article-title":"Isotretinoin and the risk of cardiovascular, cerebrovascular and thromboembolic disorders","volume":"223","author":"Berard","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.arteri.2015.08.001_bib1235","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaad.2004.06.017","article-title":"Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis","volume":"52","author":"Prodanovich","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1240","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/jdv.12768","article-title":"Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort","volume":"29","author":"Ahlehoff","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1245","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1468-3083.2012.04706.x","article-title":"Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: A nation-wide study","volume":"27","author":"Chin","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1250","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2165\/11319310-000000000-00000","article-title":"Psoriasis therapy and cardiovascular risk factors: A 12-week follow-up study","volume":"11","author":"Coimbra","year":"2010","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1255","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40265-013-0173-5","article-title":"Does treatment of psoriasis reduce the risk of cardiovascular disease?","volume":"74","author":"Churton","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.arteri.2015.08.001_bib1260","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jaad.2013.12.044","article-title":"Systemic treatment and narrowband ultraviolet B differentially affect cardiovascular risk markers in psoriasis","volume":"70","author":"Sigurdardottir","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40257-013-0052-6","article-title":"Effect of treating psoriasis on cardiovascular co-morbidities: Focus on TNF inhibitors","volume":"15","author":"Famenini","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1270","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.2011.878","article-title":"Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis","volume":"305","author":"Solomon","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.arteri.2015.08.001_bib1275","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1468-3083.2012.04500.x","article-title":"Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12\/23 biological agents for chronic plaque psoriasis: A meta-analysis of randomized controlled trials","volume":"27","author":"Tzellos","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1280","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2013.01.011","article-title":"Major cardiovascular events associated with anti-IL 12\/23 agents: A tale of two meta-analyses","volume":"68","author":"Dommasch","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1285","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaad.2013.10.053","article-title":"Counterpoint: A tale of two meta-analyses revisited","volume":"70","author":"Dommasch","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1290","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaad.2015.03.011","article-title":"Retraction notice: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assesment and Registry [PSOLAR])","volume":"73","author":"Papp","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1295","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-2133.2011.10257.x","article-title":"Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: Results of integrated analyses of data from phase II and III clinical studies","volume":"164","author":"Reich","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1300","unstructured":"Leonardi CL, Mehta NN, Lebwohl M, Cooper S, Fox T, Karpov A. Incidence of Major Adverse Cardiovascular Events With Secukinumab: A Pooled Analysis of Data From 10 Phase 2 and 3 Clinical Trials in Psoriasis. The Federation of Clinical Immunology Societies (FOCiS) Annual Meeting; Chicago, Illinois, USA.: 20143057."},{"key":"10.1016\/j.arteri.2015.08.001_bib1305","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis \u2014 results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2015.08.001_bib1310","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/09546634.2014.932324","article-title":"Clinical effects of pioglitazone, an insulin sensitizing drug, on psoriasis vulgaris and its co-morbidities, a double blinded randomized controlled trialx1","volume":"26","author":"Hafez","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.arteri.2015.08.001_bib1315","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4161\/derm.23874","article-title":"A marriage of two Methusalem drugs for the treatment of psoriasis? Arguments for a pilot trial with metformin as add-on for methotrexate","volume":"5","author":"Glossmann","year":"2013","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1320","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/bjd.12883","article-title":"Simvastatin as a novel therapeutic agent for venous ulcers: A randomized, double-blind, placebo-controlled trial","volume":"170","author":"Evangelista","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.arteri.2015.08.001_bib1325","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.arteri.2015.08.001_bib1330","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/bmj.315.7123.1636","article-title":"Choosing the best research design for each question","volume":"315","author":"Sackett","year":"1997","journal-title":"BMJ"}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916815001126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916815001126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T16:43:32Z","timestamp":1748623412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916815001126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":133,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0214916815001126"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2015.08.001","relation":{},"ISSN":["0214-9168"],"issn-type":[{"type":"print","value":"0214-9168"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuevas poblaciones con riesgo cardiovascular aumentado: enfermedad cardiovascular en las enfermedades dermatol\u00f3gicas","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2015.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}